ID
30160
Description
Study ID: 108414 Clinical Study ID: DBU108414 Study Title: TXA107979: A placebo-controlled, single blind, randomized two part study to investigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01036061 https://clinicaltrials.gov/ct2/show/NCT01036061 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK618334 Study Indication: Substance Dependence Documentation part: Logs/Repeats- Scales/Questionnaires
Link
https://clinicaltrials.gov/ct2/show/NCT01036061
Keywords
Versions (1)
- 5/16/18 5/16/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
May 16, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Tolerability, pharmacokinetics, and brain Dopamine D3 receptor occupancy of increasing repeat doses of GSK618334 in healthy adults NCT01036061
Scales/Questionnaires
- StudyEvent: ODM
Description
Simpson Angus Scale
Alias
- UMLS CUI-1
- C0041755
- UMLS CUI-2
- C0015371
- UMLS CUI-3
- C0681889
Description
The Barnes Akathisia Scale
Alias
- UMLS CUI-1
- C3541345
Description
Abnormal Involuntary Movement Scale
Alias
- UMLS CUI-1
- C0450978
Description
Profile of Mood States
Alias
- UMLS CUI-1
- C0451394
Similar models
Scales/Questionnaires
- StudyEvent: ODM
C0015371 (UMLS CUI-2)
C0681889 (UMLS CUI-3)
C0015371 (UMLS CUI [1,2])
C0681889 (UMLS CUI [1,3])